Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$120.0 - $182.95 $492,240 - $750,460
-4,102 Reduced 54.06%
3,486 $439,000
Q3 2023

Oct 31, 2023

BUY
$138.78 - $176.51 $121,571 - $154,622
876 Added 13.05%
7,588 $1.21 Million
Q2 2023

Aug 11, 2023

SELL
$138.42 - $180.31 $95,371 - $124,233
-689 Reduced 9.31%
6,712 $949,000
Q1 2023

May 11, 2023

BUY
$154.26 - $198.1 $106,285 - $136,490
689 Added 10.27%
7,401 $1.25 Million
Q4 2022

Feb 13, 2023

BUY
$162.42 - $220.56 $1.09 Million - $1.48 Million
6,712 New
6,712 $1.14 Million
Q3 2021

Nov 10, 2021

SELL
$194.77 - $324.21 $117,835 - $196,147
-605 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$165.87 - $220.95 $9,620 - $12,815
-58 Reduced 8.75%
605 $121,000
Q1 2021

May 12, 2021

SELL
$180.37 - $226.26 $4.75 Million - $5.96 Million
-26,336 Reduced 97.54%
663 $129,000
Q4 2020

Feb 10, 2021

SELL
$148.08 - $206.57 $8.85 Million - $12.3 Million
-59,752 Reduced 68.88%
26,999 $5.17 Million
Q3 2020

Nov 13, 2020

BUY
$122.51 - $158.27 $5.92 Million - $7.64 Million
48,303 Added 125.63%
86,751 $12.8 Million
Q2 2020

Aug 12, 2020

SELL
$94.33 - $140.48 $2.17 Million - $3.23 Million
-22,980 Reduced 37.41%
38,448 $4.75 Million
Q1 2020

May 14, 2020

BUY
$84.96 - $109.14 $1.52 Million - $1.95 Million
17,841 Added 40.93%
61,428 $5.93 Million
Q4 2019

Feb 12, 2020

BUY
$73.84 - $93.08 $3.22 Million - $4.06 Million
43,587 New
43,587 $4.03 Million
Q4 2017

Feb 14, 2018

SELL
$32.53 - $38.92 $881,009 - $1.05 Million
-27,083 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$36.98 - $46.06 $1 Million - $1.25 Million
27,083
27,083 $1.04 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.